Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_assertion type Assertion NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_head.
- NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_assertion description "[Advanced glycation end products (AGEs), S100/calgranulins, and HMGB1 proteins supposedly play a pivotal role in diabetes mellitus and other chronic inflammatory diseases by promoting cellular dysfunction via binding to cellular surface receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_provenance.
- NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_assertion evidence source_evidence_literature NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_provenance.
- NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_assertion SIO_000772 16037292 NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_provenance.
- NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_assertion wasDerivedFrom befree-2016 NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_provenance.
- NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_assertion wasGeneratedBy ECO_0000203 NP505291.RATD3NCiY-fnc8C04_Ige_SNWhMdv616RPMFqvqBZV9OM130_provenance.